Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomarin Pharmaceutical

59.82
+0.50000.84%
Post-market: 60.961.14+1.91%17:23 EDT
Volume:1.47M
Turnover:88.09M
Market Cap:11.47B
PE:22.11
High:61.26
Open:58.81
Low:58.74
Close:59.32
Loading ...
Jul 02, 2020

Major Issues Report

8-K - Current report
Jun 01, 2020

Major Issues Report

8-K - Current report
May 19, 2020

Major Issues Report

8-K - Current report
May 14, 2020

Major Issues Report

8-K - Current report
May 01, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 29, 2020

Major Issues Report

8-K - Current report
Apr 22, 2020

Major Issues Report

8-K - Current report
Feb 27, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 04, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 03, 2020

Major Issues Report

Current report, item 5.02
Nov 04, 2019

[Rev.]Quaterly Report

[Amend] Quarterly report [Sections 13 or 15(d)]
Oct 29, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Oct 29, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 23, 2019

Major Issues Report

Current report, items 2.02 and 9.01